Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Genitourinary 1

Conditions

Osteosarcoma 6Lymphoma 4Renal Insufficiency 3Neoplasms 2Mucositis 2Lymphoma, Large B-Cell, Diffuse 2Leukemia 2Hematologic Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Water Intoxication 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Acute Kidney Injury 1

Interventions

daratumumab 2Urination 2Plasma Exchange 2sodium sulfate 1glucarpidase 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Stents 1Spironolactone 1Renal Dialysis 1Nephrotomy 1Nephrostomy, Percutaneous 1Methotrexate 1Ischemic Preconditioning 1Hypothermia, Induced 1Hyperthermic Intraperitoneal Chemotherapy 1Hemodiafiltration 1Drug Therapy 1Cisplatin 1Cilastatin 1Antibiotic Prophylaxis 1Anesthetics 1Aminophylline 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Acute Kidney Injury × glucarpidase × Clear all
NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

BTG International Inc.

Unknown
1,000 enrolled
GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡